Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2003
06/05/2003US20030105003 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
06/05/2003US20030105001 Pro-apoptotic proteins and DNA molecules encoding them
06/05/2003US20030105000 Methods and compositions for inhibiting GRB7
06/05/2003US20030104999 Endorepellin: methods and compositions for inhibiting angiogenesis
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104996 L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
06/05/2003US20030104995 Neuroprotective methods and compositions
06/05/2003US20030104994 Preventing infections of an immunosuppressed humans, AIDS or undergoing transplantation or anti-cancer therapy; using Candida fungus gene
06/05/2003US20030104993 Promoting survival of neurons or nerve cells, stimulating cell differentiation, detecting and monitoring neuropathies; a biocompatible tubular casing having openings adapted to receive the ends of a severed nerve, promoting healing
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104991 Didemnin analogs and fragments and methods of making and using them
06/05/2003US20030104990 A cyclosporin mixture comprising a carrier select from 1,2-propylene glycol, glycerides and a surfactant; glycerol-transesterified corn oil, drug bioavailability
06/05/2003US20030104988 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
06/05/2003US20030104987 Methods of using the hyaluronan receptor for endocytosis
06/05/2003US20030104986 Streptomycin bactericides for treating infections; cultures
06/05/2003US20030104985 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates
06/05/2003US20030104984 Inhibitor of stem cell proliferation and uses thereof
06/05/2003US20030104983 A continuous infusion solution, consisting of buffer selected from the group TRIS and arginine, a zinc compound and a phenolic preservatives; treating diabetes, hyperglycemia
06/05/2003US20030104981 A mutant amino acid sequence for treating diabetes, comprising replacement, substitution of an amino acid with increasing resistance to insulin-degrading enzyme; enzyme resistance
06/05/2003US20030104980 Treating sexual desire disorders with flibanserin
06/05/2003US20030104978 A polypeptide encoded by nucleic acid constructs; recombinant host cell, transgenic animal, transgenic plant; treating blood bleeding, hemostasis
06/05/2003US20030104977 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104973 Purified, isolated and cloned nucleic acid polynucleotide encoding hypoxia-regulating genes and the proteins and antibodies specifically bind these proteins; genetic engineering
06/05/2003US20030104970 Modulating the growth state of an epithelial cell by ectopically contacting the epithelial cell, in vitro or in vivo, with hedgehog polypeptide or patched therapeutic to promote or inhibit of proliferation of epithelial cell
06/05/2003US20030104622 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
06/05/2003US20030104621 Method of expressing genes in mammalian cells
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104606 Biosensor for detection of vibrio luminescent protein; biological pest control; bactericides; gene expression inhibition
06/05/2003US20030104602 Adipocyte complement related protein zacrp3X2
06/05/2003US20030104599 Polypeptide (suv39h2) having histone methyltransferase activity; antitumor agents; meiotic chromatin; contraceptives
06/05/2003US20030104596 human desaturase gene and uses thereof
06/05/2003US20030104591 Methods and compositions for grafting functional loops into a protein
06/05/2003US20030104590 Microfabricated devices for the storage and selective exposure of chemicals and devices
06/05/2003US20030104589 Tissue adhesive using synthetic crosslinking
06/05/2003US20030104581 Biosynthesis and recovery of viricides from prokaryotic cells
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104578 Secreted in yeast; storage stability; microbiocides
06/05/2003US20030104573 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
06/05/2003US20030104571 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104553 Isolation of human chorionic gonadotropin protein through ion exchange and size exclusion chromatography
06/05/2003US20030104535 Adheson variants
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104530 Inhibiting competetive binding; maintenance of organelle equilibrium; drug resistance
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
06/05/2003US20030104521 Disease associated gene
06/05/2003US20030104520 Stable ribozyme for modulation of gene expression; in vitro diagnostic agent; regulatory sequences for medical diagnosis
06/05/2003US20030104519 Xenobiotic compound modulated expression systems and uses therefor
06/05/2003US20030104518 FIL-1 theta DNAs and polypeptides
06/05/2003US20030104517 Kinesin light chain homolog
06/05/2003US20030104516 Protein kinase npk-110
06/05/2003US20030104505 Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104487 Neuropeptide receptor and uses thereof
06/05/2003US20030104485 Antibodies specific for osteoprotegerin binding proteins and method of use
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104469 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of gastrointestinal, cancer and kidney disorders
06/05/2003US20030104455 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
06/05/2003US20030104447 Nucleotide sequences coding polypeptide for use in treatment and detection of respiratory, skin and infectious disorders
06/05/2003US20030104443 Nucleotide sequences coding polypeptide for use in treatment, diagnosis, and prevention of cancer
06/05/2003US20030104420 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
06/05/2003US20030104407 Methods for diagnosis and treatment of MDK1 signal transduction disorders
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104403 Nucleotide sequence coding transferase enzyme for use in treatment cancer
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104381 Nucleotide sequences coding polypeptide for use in treatment of heart, cancer and skin disorders
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003US20030104366 Polypeptides for use in the diagnosis and prevention of tumors; antiproliferative agents
06/05/2003US20030104356 Compounds and methods for treating and screening viral reactivation
06/05/2003US20030104351 FIZZ1 for metabolism regulation
06/05/2003US20030104082 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex.
06/05/2003US20030104064 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics
06/05/2003US20030104062 Shell-and-core dosage form approaching zero-order drug release
06/05/2003US20030104048 Pharmaceutical dosage forms for highly hydrophilic materials
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104041 Transdermal and topical administration of drugs using basic permeation enhancers
06/05/2003US20030104033 Contain caseinate and another protein, preferably soybean protein or whey; reduced rate of creaming and an enhanced shelf life.
06/05/2003US20030104013 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease
06/05/2003US20030104000 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections
06/05/2003US20030103998 Treatment of HIV and other viral infections using combinatorial therapy
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103993 HLA-DR2 binding peptides
06/05/2003US20030103992 Cadherin-like asymmetry proteins, in particular, polynucleotides, polypeptides, fusion proteins, and antibodies; for modulating immune response
06/05/2003US20030103990 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
06/05/2003US20030103987 Contacting cells of patient with protein having toxic activity of Clostridium sordellii toxin LT under conditions favoring inactivating of Ras by glucosylation of Ras'threonine 35 in cells
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103982 Therapeutic using a bispecific antibody
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103976 Anti-fas antibodies
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103972 Identification and characterization of multiple splice variants of the mu-opioid receptor gene
06/05/2003US20030103970 Natural human antibody
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003US20030103967 Administering an immunomodulator comprising at least one Fc receptor ligand for treating immune disorders such as allergies, transplanted tissue rejection and autoimmune disorders lupus, rheumatoid arthritis and multiple sclerosis
06/05/2003US20030103964 Methods for designing molecular conjugates and compositions thereof
06/05/2003US20030103959 Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
1 ... 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 ... 3163